Catalyst Biosciences Intangible Assets

Catalyst Biosciences (CBIO) currently reports a intangible assets of $0 as of March 2026. That compares with $5.1M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Catalyst Biosciences's intangible assets history and peer comparisons.

Catalyst Biosciences's intangible assets decreased from $5.1M to $0 — a 100.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Catalyst Biosciences reported $0 in intangible assets as of March 2026. That compares with $5.1M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Catalyst Biosciences, and consider following CBIO for alerts when major investors trade the stock.

Catalyst Biosciences is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CBIO with unrelated industries.